Search results

Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

Following a decade of imaging to support research and clinical trials at ANSTO and the University of Sydney’s Brain and Mind Centre at Camperdown, two PET scanners have been transferred to the University of Wollongong.

In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).

ANSTO, the home of Australia’s nuclear science expertise and the Powerhouse Museum, home of Australia’s excellence and innovation in the applied arts and sciences will collaborate on research projects, establish an Indigenous Cultural Research Scholarship and combine efforts on STEM outreach activities.

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

In a new study published in Nature Communications, researchers from UNSW have demonstrated a more sustainable alternative: an electrochemical pathway that couples carbon dioxide and nitrogen-containing species to produce urea under mild conditions.

Structure of protein involved in immune response pair revealed.

Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.

A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.

A Powerhouse exhibition was recognised with a prestigious Museums and Galleries National Award for Research at a ceremony in Perth this morning.  The Invisible Revealed exhibition was organised in collaboration with ANSTO and the University of NSW.

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

ANSTO is coordinating and facilitating the calling of pre-concept papers for the next cycle of technical cooperative project proposals under the Regional Cooperative Agreement for Research, Development and Training Related to Nuclear Science and Technology for Asia and the Pacific (RCA) | IAEA

ANSTO's Mo-99 manufacturing facility secures Australia’s ability to produce Mo-99 to meet current and future domestic demand and provide a significant proportion to support global demand.

Doping with transition metals produced stability in bismuth oxide.